Can I read Impact of Csa On Ovarian Cancer Costs on EtoBox?

Impact of Csa On Ovarian Cancer Costs by Vinayak Sudhapalli is a document available to read on EtoBox.

What is Impact of Csa On Ovarian Cancer Costs about?

The study estimates the costs of chemotherapy for recurrent ovarian cancer with and without a chemoresponse assay. Mean costs for 6 cycles were $48,758 for empiric treatment, $33,187 for assay-assisted, and $23,986 for assay-adherent, indicating significant cost savings with assay use. The findings suggest that chemoresponse assay-directed therapy may reduce treatment costs compared to traditional methods.

Author

Vinayak Sudhapalli

Language

EN